| Literature DB >> 32726578 |
Kelsey L Hickey1, Kimberley Dickson2, J Zachery Cogan1, Joseph M Replogle1, Michael Schoof3, Karole N D'Orazio4, Niladri K Sinha4, Jeffrey A Hussmann5, Marco Jost5, Adam Frost6, Rachel Green7, Jonathan S Weissman8, Kamena K Kostova9.
Abstract
Ribosome-associated quality control (RQC) pathways protect cells from toxicity caused by incomplete protein products resulting from translation of damaged or problematic mRNAs. Extensive work in yeast has identified highly conserved mechanisms that lead to degradation of faulty mRNA and partially synthesized polypeptides. Here we used CRISPR-Cas9-based screening to search for additional RQC strategies in mammals. We found that failed translation leads to specific inhibition of translation initiation on that message. This negative feedback loop is mediated by two translation inhibitors, GIGYF2 and 4EHP. Model substrates and growth-based assays established that inhibition of additional rounds of translation acts in concert with known RQC pathways to prevent buildup of toxic proteins. Inability to block translation of faulty mRNAs and subsequent accumulation of partially synthesized polypeptides could explain the neurodevelopmental and neuropsychiatric disorders observed in mice and humans with compromised GIGYF2 function. Published by Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32726578 PMCID: PMC7891188 DOI: 10.1016/j.molcel.2020.07.007
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970